Bioptik Technology Incorporation (4161.TWO) Stock
—
Valuation
Financials & Margins
About Bioptik Technology Incorporation
—
Bioptik Technology Incorporation is led by CEO Yao-Jen Tu, employs 80 people, headquartered in Zhunan, TW, publicly traded since 2012.
Bioptik Technology Incorporation (4161.TWO) stock trades at $21.25 with a market capitalization of $1.28B. The stock is valued at a price-to-earnings (P/E) ratio of 11.57, price-to-book of 1.29, price-to-sales of 1.40. Over the past 52 weeks the stock has ranged between $21.10 and $28.00, and currently trades 24.1% below its 52-week high. It pays a dividend yielding 3.27%.
On profitability, Bioptik Technology Incorporation generates a return on equity (ROE) of 11.20%, an operating margin of 6.15%, a net profit margin of 11.89%.
Official website: www.bioptik.com.tw
Bioptik Technology Incorporation (4161.TWO) — frequently asked questions
What is Bioptik Technology Incorporation (4161.TWO) stock price today?
Bioptik Technology Incorporation (4161.TWO) is currently trading at $21.25, down 0.7% today.
What is 4161.TWO P/E ratio?
Bioptik Technology Incorporation's P/E ratio is 11.57. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 4161.TWO return on equity (ROE)?
Bioptik Technology Incorporation's return on equity (ROE) is 11.20%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Bioptik Technology Incorporation's market cap?
Bioptik Technology Incorporation has a market capitalization of $1.28B.
Does 4161.TWO pay a dividend?
Yes. Bioptik Technology Incorporation currently yields 3.27%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 4161.TWO carry?
Bioptik Technology Incorporation has a debt-to-equity ratio of 0.39. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4161.TWO's profit margin?
Bioptik Technology Incorporation reports a net profit margin of 11.89% — the share of revenue left after every cost, including tax and interest.
What sector is 4161.TWO in?
Bioptik Technology Incorporation is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4161.TWO listed on?
Bioptik Technology Incorporation trades on TWO under the ticker 4161.TWO.
What is 4161.TWO's 52-week range?
Over the last year Bioptik Technology Incorporation has traded between $21.10 and $28.00.
Related — Stocks
Popular Stocks
Screens 4161.TWO currently matches
On the figures above, Bioptik Technology Incorporation passes the filters for 18 of our ready-made screens, among them Undervalued Stocks, Low PE Stocks, Undervalued Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.